You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 26, 2024

Claims for Patent: 6,323,395


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,323,395
Title: Nucleotide sequences of maize and soybean .beta.-Ketoacyl-Acyl Carrier Protein Synthase II and their use in the regulation of fatty acid content of oil
Abstract:Genes encoding .beta.-Ketoacyl-Acyl Carrier Protein Synthase II have been isolated from maize and soybean tissues. These proteins, when expressed in a plant, can alter the saturate levels of the oil.
Inventor(s): Rubin-Wilson; Beth C. (Indianapolis, IN), Young; Scott A. (Indianapolis, IN), Folkerts; Otto (Guilford, CT)
Assignee: Dow AgroSciences LLC (Indianapolis, IN)
Application Number:09/212,609
Patent Claims:1. An isolated DNA construct comprising, in the 5' to 3' direction:

a promoter regulatory element,

a nucleic acid fragment that encodes a .beta.-ketoacyl-acyl carrier protein synthase II isolated from maize or soybean, said nucleic acid fragment being selected from the group consisting of SEQ ID NO:5, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:14, SEQ ID NO:16, SEQ ID NO:17, SEQ ID NO:19, SEQ ID NO:21, and SEQ ID NO:22, and

a transcriptional terminator sequence.

2. The DNA construct of claim 1 wherein said promoter regulatory element is selected from the group consisting of ubiquitin promoter, maize globulin promoter, maize streak virus enhancer region, 35s promoter, doubly enhanced 35s promoter and the first intron of maize alcohol dehydrogenase.

3. The DNA construct of claim 1 wherein said nucleic acid fragment is in the sense orientation.

4. The DNA construct of claim 1 wherein said nucleic acid fragment is in an antisense orientation.

5. An isolated nucleic acid fragment selected from the group consisting of SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:5, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO:12, SEQ ID NO:14, SEQ ID NO:16, SEQ ID NO:17, SEQ ID NO:19, SEQ ID NO:21, SEQ ID NO:22, SEQ ID NO:24, SEQ ID NO:25, SEQ ID NO:26, SEQ ID NO:27, and SEQ ID NO:28.

6. A DNA isolate consisting essentially of a DNA sequence encoding .beta.-ketoacyl-acyl carrier protein synthase II isolated from maize or soybean, wherein said .beta.-ketoacyl-acyl carrier protein synthase II has an amino acid sequence selected from the group consisting of SEQ ID NO:4, SEQ ID NO:6, SEQ ID NO:9, SEQ ID NO:13, SEQ ID NO:15, SEQ ID NO:18, SEQ ID NO:20, and SEQ ID NO:23.

7. A plant cell containing a DNA construct of claim 1.

8. The plant cell of claim 7 wherein said promoter regulatory element is selected from the group consisting of ubiquitin promoter, maize globulin promoter, maize streak virus enhancer region, 35s promoter, doubly enhanced 35s promoter and the first intron of maize alcohol dehydrogenase.

9. The plant cell of claim 7 wherein said nucleic acid fragment is in the sense orientation.

10. The plant cell of claim 7 wherein said nucleic acid fragment is in an antisense orientation.

11. The plant cell of claim 7 wherein said plant cell is selected from the group consisting of soybean, Brassicaceae sp., canola, rape, sunflower, flax, safflower, coconut, palm, olive, peanut, cotton, castor bean, coriander, Crambe sp., Cuphea sp., Euphorbia sp., Oenothera sp., jojoba, Lesquerella sp., marigold, Limnanthes sp., Vernonia sp., Sinapis alba, cocoa, and maize.

12. The plant cell of claim 11 wherein said plant cell is a seed embryo cell.

13. A transgenic plant produced from the plant cell of claim 7.

14. A seed, and the progeny thereof, produced from the transgenic plant of claim 13.

15. A method of producing a plant oil having altered levels of fatty acids comprising:

growing a plant cell having integrated into its genome a construct comprising, in the 5' to 3' direction, a promoter regulatory element functional in a plant cell, a nucleic acid fragment that encodes a .beta.-ketoacyl-acyl carrier protein synthase II isolated from maize or soybean, said nucleic acid fragment being selected from the group consisting of SEQ ID NO:5, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:14, SEQ ID NO:16, SEQ ID NO:17, SEQ ID NO:19, SEQ ID NO:21, and SEQ ID NO:22, and a transcriptional terminator sequence, wherein overexpression of .beta.-ketoacyl-acyl carrier protein synthase II gene results in the production of altered levels of fatty acid in said plant cell.

16. The method of claim 15 wherein said plant cell is selected from the group consisting of soybean, Brassicaceae sp., canola, rape, sunflower, flax, safflower, coconut, palm, olive, peanut, cotton, castor bean, coriander, Crambe sp., Cuphea sp., Euphorbia sp., Oenothera sp., jojoba, Lesquerella sp., marigold, Limnanthes sp., Vernonia sp., Sinapis alba, cocoa, and maize.

17. The method of claim 15 wherein said plant cell is a seed embryo cell.

18. The method of claim 15 comprising the further step of regenerating a transgenic plant from said plant cell.

19. The method of claim 18 wherein said plant oil is isolated from said transgenic plant and the progeny thereof.

20. The method of claim 15 wherein said nucleic acid fragment is in the sense orientation.

21. The method of claim 15 wherein said nucleic acid fragment encoding is in an antisense orientation.

22. The isolated nucleic acid fragment of claim 5 selected from the group consisting of SEQ ID NO:5, SEQ ID NO:7, SEQ ID NO:8, SEQ ID NO:14, SEQ ID NO:16, SEQ ID NO:17, SEQ ID NO:19, SEQ ID NO:21, and SEQ ID NO:22.

Details for Patent 6,323,395

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 06/04/1986 ⤷  Try a Trial 2017-12-24
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 ⤷  Try a Trial 2017-12-24
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b Injection 103132 ⤷  Try a Trial 2017-12-24
Aimmune Therapeutics, Inc. PALFORZIA peanut (arachis hypogaea) allergen powder Powder 125696 01/31/2020 ⤷  Try a Trial 2017-12-24
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.